Company profile
Nona Biosciences
Empowering Global Biotherapeutic Innovation
- Industry
- Biotechnology Research
- Employees
- 86
- Headquarters
- Cambridge, Massachusetts
- Founded
- 2022
- LinkedIn followers
- 16,117
- Office locations
- 1
Nona Biosciences company summary
Nona Biosciences is a company in the Biotechnology Research industry, headquartered in Cambridge, Massachusetts, founded in 2022. On LinkedIn the company has around 86 employees and 16,117 followers.
What technology does Nona Biosciences use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Nona Biosciences
Nona Biosciences is a biotechnology company advancing biotherapeutic discovery and development through proprietary antibody and modality-enabling technologies. Built on fully human antibody platforms, including Harbour Mice®, which generate both heavy chain-only (HCAb) and classical IgG (H2L2) antibodies, Nona enables high molecular diversity, strong developability, and broad therapeutic applicability. At the core of Nona’s technology ecosystem is Modalities-on-Demand™, a platform framework designed to enable the rapid conversion of antibody leads into diverse therapeutic formats. This includes bispecific and multispecific antibodies, T cell engagers, ADC and XDC formats, TCR-mimic antibodies, and CAR- and mRNA-based therapeutics. This modality-driven approach allows a single antibody foundation to be flexibly engineered across multiple architectures, supporting efficient program design and adaptability across evolving therapeutic strategies. These capabilities are further enhanced by Hu-mAtrIx™, Nona’s AI-driven platform for both discovery and development, which enables data-informed optimization across antibody generation, engineering, and translational workflows. By integrating AI with experimental platforms, Nona supports improved candidate selection, developability profiling, and accelerated progression through key development milestones. Together, these technologies support efficient progression within Nona’s I to I® framework, advancing programs from early concept and target validation through IND-enabling studies and toward clinical evaluation. Nona’s integrated capabilities span immunization, screening, engineering, and downstream development support, including pathways aligned with Investigator-Initiated Trials (IITs) and early clinical strategies through global partnerships.
Where is Nona Biosciences located?
Nona Biosciences lists 1 location.
Compare companies similar to Nona Biosciences
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Nona Biosciences nonabio.com | Biotechnology Research | 86 | 2022 | Cambridge, Massachusetts |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Nona Biosciences
What does Nona Biosciences do?
Nona Biosciences is a biotechnology company advancing biotherapeutic discovery and development through proprietary antibody and modality-enabling technologies. Built on fully human antibody platforms, including Harbour Mice®, which generate both heavy chain-only (HCAb) and classical IgG (H2L2) antibodies, Nona enables high molecular diversity, strong developability, and broad therapeutic applicability. At the core of Nona’s technology ecosystem is Modalities-on-Demand™, a platform framework designed to enable the rapid conversion of antibody leads into diverse therapeutic formats. This includes bispecific and multispecific antibodies, T cell engagers, ADC and XDC formats, TCR-mimic antibodies, and CAR- and mRNA-based therapeutics. This modality-driven approach allows a single antibody foundation to be flexibly engineered across multiple architectures, supporting efficient program design and adaptability across evolving therapeutic strategies. These capabilities are further enhanced by Hu-mAtrIx™, Nona’s AI-driven platform for both discovery and development, which enables data-informed optimization across antibody generation, engineering, and translational workflows. By integrating AI with experimental platforms, Nona supports improved candidate selection, developability profiling, and accelerated progression through key development milestones. Together, these technologies support efficient progression within Nona’s I to I® framework, advancing programs from early concept and target validation through IND-enabling studies and toward clinical evaluation. Nona’s integrated capabilities span immunization, screening, engineering, and downstream development support, including pathways aligned with Investigator-Initiated Trials (IITs) and early clinical strategies through global partnerships.
How many employees does Nona Biosciences have?
Nona Biosciences has around 86 employees on LinkedIn.
Where is Nona Biosciences headquartered?
Nona Biosciences is headquartered in Cambridge, Massachusetts.
When was Nona Biosciences founded?
Nona Biosciences was founded in 2022.
Build a lead list from companies like Nona Biosciences
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.